GAGLIANO, Teresa
GAGLIANO, Teresa
DMED - DIPARTIMENTO DI MEDICINA
An integrated genomic-transcriptomic approach supports a role for the proto-oncogene BCL3 in atherosclerosis
2015-01-01 Marchetti, G.; Girelli, D.; Zerbinati, C.; Lunghi, B.; Friso, S.; Meneghetti, S.; Coen, M.; Gagliano, T.; Guastella, G.; Bochaton-Piallat, M. -L.; Pizzolo, F.; Mascoli, F.; Malerba, G.; Bovolenta, M.; Ferracin, M.; Olivieri, O.; Bernardi, F.; Martinelli, N.
Androgen receptor signaling regulates the transcriptome of prostate cancer cells by modulating global alternative splicing
2020-01-01 Shah, K.; Gagliano, T.; Garland, L.; O'Hanlon, T.; Bortolotti, D.; Gentili, V.; Rizzo, R.; Giamas, G.; Dean, M.
Cabergoline reduces cell viability in non functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion
2013-01-01 Gagliano, T.; Filieri, C.; Minoia, M.; Buratto, M.; Tagliati, F.; Ambrosio, M. R.; Lapparelli, M.; Zoli, M.; Frank, G.; Degli Uberti, E.; Zatelli, M. C.
Calmodulin expression distinguishes the smooth muscle cell population of human carotid plaque
2013-01-01 Coen, M.; Marchetti, G.; Palagi, P. M.; Zerbinati, C.; Guastella, G.; Gagliano, T.; Bernardi, F.; Mascoli, F.; Bochaton-Piallat, M. -L.
Cancer gene therapy 2020: highlights from a challenging year
2021-01-01 Giamas, G.; Gagliano, T.
Changes in chromatin accessibility and transcriptional landscape induced by HDAC inhibitors in TP53 mutated patient-derived colon cancer organoids
2024-01-01 Gagliano, Teresa; Kerschbamer, Emanuela; Baccarani, Umberto; Minisini, Martina; Di Giorgio, Eros; Dalla, Emiliano; Weichenberger, Christian X; Cherichi, Vittorio; Terrosu, Giovanni; Brancolini, Claudio
Decoding the Tumour Microenvironment: Molecular Players, Pathways, and Therapeutic Targets in Cancer Treatment
2024-01-01 Malavasi, E.; Adamo, M.; Zamprogno, E.; Vella, V.; Giamas, G.; Gagliano, T.
Direct Effects of Anti-Angiogenic Therapies on Tumor Cells: VEGF Signaling
2017-01-01 Simon, T.; Gagliano, T.; Giamas, G.
Editorial: Gender pressure in cancer: susceptibility, progression and treatment of the neoplastic disease
2023-01-01 Bacci, M.; Gagliano, T.
EGF and IGF1 affect sunitinib activity in BP-NEN: New putative targets beyond VEGFR?
2019-01-01 Bresciani, G.; Ditsiou, A.; Cilibrasi, C.; Vella, V.; Rea, F.; Schiavon, M.; Cavallesco, N. G.; Giamas, G.; Zatelli, M. C.; Gagliano, T.
Epigenetic mechanisms beyond tumour–stroma crosstalk
2021-01-01 Gagliano, T.; Brancolini, C.
Estrogen receptor status heterogeneity in breast cancer tumor: role in response to endocrine treatment
2023-01-01 Malavasi, Eleonora; Giamas, Georgios; Gagliano, Teresa
Evaluation of Spheroid 3D Culture Methods to Study a Pancreatic Neuroendocrine Neoplasm Cell Line
2019-01-01 Bresciani, Giulia; J Hofland, Leo; Dogan, Fadime; Giamas, Georgios; Gagliano, Teresa; Chiara Zatelli, Maria
HDACs and the epigenetic plasticity of cancer cells: Target the complexity
2022-01-01 Brancolini, C.; Gagliano, T.; Minisini, M.
IGF-I influences everolimus activity in medullary thyroid carcinoma
2015-01-01 Gentilin, E.; Di Pasquale, C.; Rossi, M.; Tagliati, F.; Gagliano, T.; Rossi, R.; Pelizzo, M.; Boschin, I. M.; degli Uberti, E. C.; Zatelli, M. C.
Inhibition of epithelial growth factor receptor can play an important role in reducing cell growth and survival in adrenocortical tumors
2015-01-01 Gagliano, T.; Gentilin, E.; Tagliati, F.; Benfini, K.; Di Pasquale, C.; Feo, C.; Falletta, S.; Riva, E.; Degli Uberti, E.; Zatelli, M. C.
Inhibitory effects of mitotane on viability and secretory activity in mouse gonadotroph cell lines
2014-01-01 Gentilin, E.; Mole, D.; Gagliano, T.; Minoia, M.; Ambrosio, M. R.; degli Uberti, E. C.; Zatelli, M. C.
Kinome-Wide Synthetic Lethal Screen Identifies PANK4 as a Modulator of Temozolomide Resistance in Glioblastoma
2024-01-01 Vella, V.; Ditsiou, A.; Chalari, A.; Eravci, M.; Wooller, S. K.; Gagliano, T.; Bani, C.; Kerschbamer, E.; Karakostas, C.; Xu, B.; Zhang, Y.; Pearl, F. M. G.; Lopez, G.; Peng, L.; Stebbing, J.; Klinakis, A.; Giamas, G.
LMTK3 confers chemo-resistance in breast cancer
2018-01-01 Stebbing, J.; Shah, K.; Lit, L. C.; Gagliano, T.; Ditsiou, A.; Wang, T.; Wendler, F.; Simon, T.; Szabo, K. S.; O'Hanlon, T.; Dean, M.; Roslani, A. C.; Cheah, S. H.; Lee, S. -C.; Giamas, G.
LMTK3 inhibition affects microtubule stability
2021-01-01 Cilibrasi, Chiara; Ditsiou, Angeliki; Papakyriakou, Athanasios; Mavridis, George; Eravci, Murat; Stebbing, Justin; Gagliano, Teresa; Giamas, Georgios
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| An integrated genomic-transcriptomic approach supports a role for the proto-oncogene BCL3 in atherosclerosis | 1-gen-2015 | Marchetti, G.; Girelli, D.; Zerbinati, C.; Lunghi, B.; Friso, S.; Meneghetti, S.; Coen, M.; Gagliano, T.; Guastella, G.; Bochaton-Piallat, M. -L.; Pizzolo, F.; Mascoli, F.; Malerba, G.; Bovolenta, M.; Ferracin, M.; Olivieri, O.; Bernardi, F.; Martinelli, N. | |
| Androgen receptor signaling regulates the transcriptome of prostate cancer cells by modulating global alternative splicing | 1-gen-2020 | Shah, K.; Gagliano, T.; Garland, L.; O'Hanlon, T.; Bortolotti, D.; Gentili, V.; Rizzo, R.; Giamas, G.; Dean, M. | |
| Cabergoline reduces cell viability in non functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion | 1-gen-2013 | Gagliano, T.; Filieri, C.; Minoia, M.; Buratto, M.; Tagliati, F.; Ambrosio, M. R.; Lapparelli, M.; Zoli, M.; Frank, G.; Degli Uberti, E.; Zatelli, M. C. | |
| Calmodulin expression distinguishes the smooth muscle cell population of human carotid plaque | 1-gen-2013 | Coen, M.; Marchetti, G.; Palagi, P. M.; Zerbinati, C.; Guastella, G.; Gagliano, T.; Bernardi, F.; Mascoli, F.; Bochaton-Piallat, M. -L. | |
| Cancer gene therapy 2020: highlights from a challenging year | 1-gen-2021 | Giamas, G.; Gagliano, T. | |
| Changes in chromatin accessibility and transcriptional landscape induced by HDAC inhibitors in TP53 mutated patient-derived colon cancer organoids | 1-gen-2024 | Gagliano, Teresa; Kerschbamer, Emanuela; Baccarani, Umberto; Minisini, Martina; Di Giorgio, Eros; Dalla, Emiliano; Weichenberger, Christian X; Cherichi, Vittorio; Terrosu, Giovanni; Brancolini, Claudio | |
| Decoding the Tumour Microenvironment: Molecular Players, Pathways, and Therapeutic Targets in Cancer Treatment | 1-gen-2024 | Malavasi, E.; Adamo, M.; Zamprogno, E.; Vella, V.; Giamas, G.; Gagliano, T. | |
| Direct Effects of Anti-Angiogenic Therapies on Tumor Cells: VEGF Signaling | 1-gen-2017 | Simon, T.; Gagliano, T.; Giamas, G. | |
| Editorial: Gender pressure in cancer: susceptibility, progression and treatment of the neoplastic disease | 1-gen-2023 | Bacci, M.; Gagliano, T. | |
| EGF and IGF1 affect sunitinib activity in BP-NEN: New putative targets beyond VEGFR? | 1-gen-2019 | Bresciani, G.; Ditsiou, A.; Cilibrasi, C.; Vella, V.; Rea, F.; Schiavon, M.; Cavallesco, N. G.; Giamas, G.; Zatelli, M. C.; Gagliano, T. | |
| Epigenetic mechanisms beyond tumour–stroma crosstalk | 1-gen-2021 | Gagliano, T.; Brancolini, C. | |
| Estrogen receptor status heterogeneity in breast cancer tumor: role in response to endocrine treatment | 1-gen-2023 | Malavasi, Eleonora; Giamas, Georgios; Gagliano, Teresa | |
| Evaluation of Spheroid 3D Culture Methods to Study a Pancreatic Neuroendocrine Neoplasm Cell Line | 1-gen-2019 | Bresciani, Giulia; J Hofland, Leo; Dogan, Fadime; Giamas, Georgios; Gagliano, Teresa; Chiara Zatelli, Maria | |
| HDACs and the epigenetic plasticity of cancer cells: Target the complexity | 1-gen-2022 | Brancolini, C.; Gagliano, T.; Minisini, M. | |
| IGF-I influences everolimus activity in medullary thyroid carcinoma | 1-gen-2015 | Gentilin, E.; Di Pasquale, C.; Rossi, M.; Tagliati, F.; Gagliano, T.; Rossi, R.; Pelizzo, M.; Boschin, I. M.; degli Uberti, E. C.; Zatelli, M. C. | |
| Inhibition of epithelial growth factor receptor can play an important role in reducing cell growth and survival in adrenocortical tumors | 1-gen-2015 | Gagliano, T.; Gentilin, E.; Tagliati, F.; Benfini, K.; Di Pasquale, C.; Feo, C.; Falletta, S.; Riva, E.; Degli Uberti, E.; Zatelli, M. C. | |
| Inhibitory effects of mitotane on viability and secretory activity in mouse gonadotroph cell lines | 1-gen-2014 | Gentilin, E.; Mole, D.; Gagliano, T.; Minoia, M.; Ambrosio, M. R.; degli Uberti, E. C.; Zatelli, M. C. | |
| Kinome-Wide Synthetic Lethal Screen Identifies PANK4 as a Modulator of Temozolomide Resistance in Glioblastoma | 1-gen-2024 | Vella, V.; Ditsiou, A.; Chalari, A.; Eravci, M.; Wooller, S. K.; Gagliano, T.; Bani, C.; Kerschbamer, E.; Karakostas, C.; Xu, B.; Zhang, Y.; Pearl, F. M. G.; Lopez, G.; Peng, L.; Stebbing, J.; Klinakis, A.; Giamas, G. | |
| LMTK3 confers chemo-resistance in breast cancer | 1-gen-2018 | Stebbing, J.; Shah, K.; Lit, L. C.; Gagliano, T.; Ditsiou, A.; Wang, T.; Wendler, F.; Simon, T.; Szabo, K. S.; O'Hanlon, T.; Dean, M.; Roslani, A. C.; Cheah, S. H.; Lee, S. -C.; Giamas, G. | |
| LMTK3 inhibition affects microtubule stability | 1-gen-2021 | Cilibrasi, Chiara; Ditsiou, Angeliki; Papakyriakou, Athanasios; Mavridis, George; Eravci, Murat; Stebbing, Justin; Gagliano, Teresa; Giamas, Georgios |